Paediatric Clinical Research
Infrastructure Network

PedCRIN Final Event

Fostering International Paediatric Clinical Research

Paediatric multinational clinical trials are essential to boost paediatric research but also must face the difficulties transnational projects normally bring. PedCRIN final event  focused on the challenges in international and multicentric paediatric clinical trials and included several panels where the setup, planning and conduction phases of these studies was discussed and analysed.  

Additionally, our consortium experts presented the main outcomes of the project (i.e supporting tools, methodologies, identified gaps, etc.) and debated on future initiatives and collaborations

Recording links

Part 1

 

 

 

 

 

 

 

 

 

Part 2

Agenda

Welcome 

9:30 - 9:35

Welcome

9:35 - 9:50

Introduction

Jacques Demotes,  European Clinical Research Infrastructure Network

Setting the scene- Multinational paediatric clinical trials: challenges and benefits

9:50 - 10:00

Introduction

Session Chair Pirkko Lepola, Helsinki University Hospital

10:00 - 10:10

YPAGs contribution to the PedCRIN project (To be confirmed)

10:10 - 10:20

Investigator perspective

Siri Merete Brændvik, St.Olavs University Hospital/Norwegian University of Science and Technology

10:20 - 10:30

Academic sponsor perspective

Rabia Hussain, University College Dublin

10:30 - 10:40

Questions and Discussion

Planning phase: PedCRIN response (Support to the design and set-up)

10:40 - 10:45

Introduction

Session Chair Saskia de Wildt, Radboud University Medical Center

10:45 - 10:55

PedCRIN Survey results

Lucia Ruggieri, Gianni Benzi Pharmacological Research Foundation

10:55 - 11:10

Tools developed (WP3 and WP5)

Evelyne Jacqz-Aigrain, The French National Institute of Health and Medical Research

Cristina Manfredi, Consorzio per Valutazioni Biologiche e Farmacologiche

Begonya Nafria Escalera, Hospital Sant Joan de Déu

Eric Vermeulen, Patient Alliance for Rare and Genetic Diseases

11:10 - 11:30

Questions and Answers 

11:30 - 11:40

BREAK

Conduct phase: PedCRIN response- (Support to the conduct and management)

11:40 - 12:15

Panel discussion to address the conduct and management phase, the tools developed for the management, the importance of qualified resources (involvement of national network of clinical trials units with feedback from CTUs involved) and operational questions such as ethics & regulatory issues, data etc.

Session Chair: Saskia de Wildt, Radboud University Medical Center

Panelists:

Kateřina Nebeská, Masaryk University

Kristyna Noskova, European Clinical Research Infrastructure Network

Pascale Wenger, Swiss Clinical Trial Organisation

Sabine Klager, European Clinical Research Infrastructure Network

Rabia Hussain, University College Dublin

Colm O'Donnell, University College Dublin & National Maternity Hospital

The future- Beyond PedCRIN project- Synergies with the existing networks and initiatives, how the paediatric community can benefit from on-going ECRIN activities

12:15 - 12:25

Introduction

Session Chair Donato Bonifazi, Consorzio per Valutazioni Biologiche e Farmacologiche

12:25 - 12:45

Synergy with c4c project

Mark Turner, University of Liverpool,

Synergy with ERNs –EJP-RD,

Luca Sangiorgi, Rizzoli Orthopaedic Institute

Beyond PedCRIN-ECRIN activities of interest for the paediatric community

Jacques Demotes,  European Clinical Research Infrastructure Network

12:45 - 12:55

Questions and Discussion

12:55 - 13:00

Closing remarks

Jacques Demotes and EU commission (To be confirmed)